drugset / Trial / NCT07531043

Efficacy and Safety of FID 123472 Ophthalmic Solution for Ocular Redness in Adults

NCT07531043

Phase 3 Not yet recruiting 230 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of an investigational ophthalmic solution in adults with ocular redness due to minor eye irritations.

Timeline

Start
2026-10
Primary completion
2027-02
Completion
2027-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Apraclonidine Small molecule 0.125 % Topical

Indications